SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001479290-24-000038
Filing Date
2024-02-28
Accepted
2024-02-28 16:33:37
Documents
115
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rvnc-20231231.htm   iXBRL 10-K 2741282
2 EX-4.4 ex_44xdescriptionsofsecuri.htm EX-4.4 31449
3 EX-10.32 ex_1032xmanagementbonuspla.htm EX-10.32 4269
4 EX-21.1 ex_211listofsubsidiariesxf.htm EX-21.1 1549
5 EX-23.1 ex_231xpublicaccountingfir.htm EX-23.1 2186
6 EX-31.1 ex_311xcertificationofpeox.htm EX-31.1 8110
7 EX-31.2 ex_312xcertificationofpfox.htm EX-31.2 8207
8 EX-32.1 ex_321xcertificationofpeox.htm EX-32.1 5530
9 EX-32.2 ex_322xcertificationofpfox.htm EX-32.2 5581
10 EX-97.1 ex_971xincentivecompensati.htm EX-97.1 40911
16 rvnc-20231231_g1.jpg GRAPHIC 282626
  Complete submission text file 0001479290-24-000038.txt   13062494

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20231231.xsd EX-101.SCH 77012
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20231231_cal.xml EX-101.CAL 138759
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20231231_def.xml EX-101.DEF 401752
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20231231_lab.xml EX-101.LAB 1064399
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20231231_pre.xml EX-101.PRE 703869
117 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20231231_htm.xml XML 1735945
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36297 | Film No.: 24696053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)